Effects of type 2 cytokines on glomerular epithelial cells

Experimental Nephrology

Volumn 9, Issue 4, 2001, Pages 275-283

  Parry, Robin G ^a,b   Gillespie, Kathleen M ^a   Mathieson, Peter W ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

Author keywords

Cytokine receptors; Cytokines; Glomerular epithelial cells; Vascular endothelial growth factor

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GLOMERULUS EPITHELIUM; GLOMERULUS FILTRATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034944074     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052622     Document Type: Article

References (68)

1. The renal glomerulus - The structural basis of ultrafiltration
2. Structure and function of podocytes: An update
3. Dysfunctions of cell biological mechanisms of visceral epithelial cell (podocytes) in glomerular diseases
4. Regulation of podocyte structure during the development of nephrotic syndrome
5. Pathogenesis of lipid nephrosis: A disorder of T-cell function
6. Is lipoid nephrosis an 'allergic' disease?
7. Is adult idiopathic nephrotic syndrome food allergy?
8. Functions of IL-4 and control of its expression
9. Interleukin-4 and the genetics of atopy
10. Requirement for IL-13 independently of IL-4 in experimental asthma
11. Interleukin-13: Central mediator of allergic asthma
12. Converging and diverging properties of human interleukin-4 and interleukin-10
13. Interleukin-10: Biology, role in inflammation and auto-immunity
14. Differentiation and functions of T-cell subsets
15. Switching off renal inflammation by anti-inflammatory mediators: The facts, the promise and the hope
16. Th1 and Th2 T-helper cell subsets affect patterns of injury and outcomes in glomerulonephritis
17. Vascular permeability factor mRNA and protein expression in human kidney
18. Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney
19. The biology of vascular endothelial growth factor
20. Analysis of mouse glomerular podocyte mRNA by single cell reverse transcription-polymerase chain reaction
21. 148 mRNA, a novel truncated splice variant
22. The human gene for vascular endothelial growth factor
23. 125I]VEGF binding sites
24. Vascular endothelial growth factor is an essential molecule for mouse kidney development. Glomerulogenesis and nephrogenesis
25. Vascular entodhelial growth factor induces endothelial fenestrations in ivitro
26. Induction of vascular endothelial growth factor gene expression by interleukin-1β in rat aortic smooth muscle cells
27. Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells
28. Single-step method of RNA isolation by acid guanidium thiocyanate phenol chloroform extraction
29. Interleukin-13, an interleukin-4-like cytokine that acts on monocytes and B cells, but not on T cells
30. An interleukin (IL)-4 mutant protein inhibits both IL-4 and IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: Support for a common component shared by IL-4 and IL-13 receptors
31. Interleukin-2 receptor gamma chain: A functional component of the interleukin-4 receptor
32. cDNA cloning and characterization of the human interleukin-13 receptor alpha chain
33. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain
34. The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor
35. The murine IL-13 receptor molecular cloning, characterization, and comparison with murine IL-13 receptor alpha-1
36. The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: Overexpression of the nonsignaling interleukin-13 receptor alpha
37. The orphan receptor CRF2-4 is an essential subunit of the interleukin-10 receptor
38. Identification and functional characterisation of a second chain of the interleukin-10 receptor complex
39. Involvement of IL-4 in human glomerulonephritis: An in situ hybridization study of IL-4 mRNA and IL-4 receptor mRNA
40. Interleukin-4 and interleukin-13 act on glomerular visceral epithelial cells
41. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia
42. Interleukin-4 is an immunoregulatory cytokine for glomerular epithelial cells which expressed interleukin-4 receptor (abstract)
43. Rat glomerular epithelial cells in culture: Parietal or visceral epithelial in origin
44. Cellular outgrowth from isolated glomeruli. Origin and characterisation
45. Autoantibodies to glomerular antigens in patients with Wegener's granulomatosis
46. Rat glomerular epithelial cells in culture express characteristics of parietal, not visceral, epithelium
47. Differential control of cytokeratins and vimentin synthesis by cell-cell contact and cell spreading in cultured epithelial cells
48. Expression of vimentin and cytokeratin types of intermediate filament protein in developing and adult human kidneys
49. Induction of differentiation in cultured rat and human podocytes
50. Cell cycle regulation and differentiation in the human podocyte lineage
51. Culture of endothelial cells from baboon and human glomeruli
52. Characterisation of myosin heavy and light chains in cultured mesangial cells
53. Podocytes in glomerulus of rat kidney express a characteristic 55-kD protein
54. Synaptopodin: An actin-associated protein in telencephalic dendrites and renal podocytes
55. Interleukin-4 ameliorates experimental glomerulonephritis and upregulates glomerular gene expression of IL-1 decoy receptor
56. Interleukin-4 ameliorates crescentic glomerulonephritis in Wistar-Kyoto rats
57. Interleukin-4 and interleukin-10 attenuate established crescentic glomerulonephritis in mice
58. Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis
59. T-lymphocyte populations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome
60. Increased IL-2, IL-4 and interferon-gamma in steroid-sensitive nephrotic syndrome
61. Upregulation of interleukin-4 and CD23/Fc epsilon RII in miminal change nephrotic syndrome
62. Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: Evidence for increased IL-13 mRNA expression in relapse
63. Increased production of interleukin-4 in children with simple idiopathic nephrotic syndrome
64. Involvement of interleukin (IL)-13, but not IL-4, in spontaneous IgE and IgG4 production in ne-phrotic syndrome
65. Studies on the role of interleukin-4 and Fc epsilon RII in the pathogenesis of minimal change nephrotic syndrome
66. Interleukin-4 cooperates with interleukin-10 to inhibit vascular permeability factor release by peripheral blood mononuclear cells from patients with minimal change nephrotic syndrome
67. Interleukin-10 inhibits vascular permeability factor release by peripheral blood mononuclear cells in patients with lipoid nephrosis
68. Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient